Immobilization of anticoagulant-loaded liposomes on cell surfaces by DNA hybridization

Biomaterials

Volumn 32, Issue 31, 2011, Pages 7971-7977

  Chen, Hao ^a   Teramura, Yuji ^b   Iwata, Hiroo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Argatroban; Islet of Langerhans; Liposome; Poly(ethylene glycol) lipid; PolyDNA hybridization; Surface modification

Indexed keywords

AMPHIPHILICS; ARGATROBAN; CELL SURFACES; CELL THERAPY; CULTURE MEDIUM; DNA HYBRIDIZATION; GLUCOSE CONCENTRATION; INSULIN RELEASE; ISLETS OF LANGERHANS; LANGERHANS; POLYDNA HYBRIDIZATION; REGENERATIVE MEDICINE; SMALL MOLECULES; VERSATILE METHODS;

CELL MEMBRANES; ETHYLENE; GLUCOSE; GLYCOLS; GRAFTS; LIPOSOMES; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; SURFACE REACTIONS; TISSUE;

CELL IMMOBILIZATION;

ARGATROBAN; DNA; GLUCOSE; INSULIN; LIPOSOME; MACROGOL; PHOSPHOLIPID DERIVATIVE;

ANTICOAGULATION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; DNA HYBRIDIZATION; DRUG DELIVERY SYSTEM; DRUG IMPLANTATION; DRUG RELEASE; HUMAN; HUMAN CELL; INSULIN RELEASE; PANCREAS ISLET; PRIORITY JOURNAL;

ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; CELL LINE, TUMOR; CELL MEMBRANE; DNA; FLUORESCENT DYES; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; NUCLEIC ACID HYBRIDIZATION; PIPECOLIC ACIDS;

EID: 80051821867     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.07.002     Document Type: Article

References (21)

1. Ryan E.A., Lakey J.R., Rajotte R.V., Korbutt G.S., Kin T., Imes S., et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001, 50:710-719.
2. Davalli A.M., Scaglia L., Zangen D.H., Hollister J., Bonner-Weir S., Weir G.C. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996, 45:1161-1167.
3. Van der Windt D.J., Bottino R., Casu A., Campanile N., Cooper D.K.C. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 2007, 14:288-297.
4. Bennet W., Sundberg B., Groth C.G., Brendel M.D., Brandhorst D., Brandhorst H., et al. Incompatibility between human blood and isolated islets of Langerhans: a fi{ligature}nding with implications for clinical intraportal islet transplantation?. Diabetes 1999, 48:1907-1914.
5. Moberg L., Johansson H., Lukinius A., Berne C., Foss A., Källen R., et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002, 360:2039-2045.
6. Johansson H., Lukinius A., Moberg L., Lundgren T., Berne C., Foss A., et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005, 54:1755-1762.
7. Johansson H., Gotoa M., Siegbahnc A., Elguea G., Korsgrena O., Nilsson B. Lowmolecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 2006, 6:305-312.
8. Ozmen L., Ekdahl K.N., Elgue G., Larsson R., Korsgren O., Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitormelagatran in clinical islet transplantation. Diabetes 2002, 51:1779-1784.
9. Contreras J.L., Eckstein C., Smyth C.A., Bilbao G., Vilatoba M., Ringland S.E., et al. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 2004, 53:2804-2814.
10. Cabric S., Sanchez J., Lundgren T., Foss A., Felldin M., Kallen R., et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 2007, 56:2008-2015.
11. Stabler C.L., Sun X.L., Cui W., Wilson J.T., Haller C.A., Chaikof E.L. Surface Re-engineering of pancreatic islets with Recombinant azido-Thrombomodulin. Bioconjug Chem 2007, 18:1713-1715.
12. Totani T., Teramura Y., Iwata H. Immobilization of urokinase on the islet surface by amphiphilic poly(vinyl alcohol) that carries alkyl side chains. Biomaterials 2008, 29:2878-2883.
13. Teramura Y., Iwata H. Islets surface modification prevents blood-mediated inflammatory responses. Bioconjug Chem 2008, 19:1389-1395.
14. Teramura Y., Iwata H. Bioartificial pancreas Microencapsulation and conformal coating of islet of Langerhans. Adv Drug Deliv Rev 2010, 62:827-840.
15. Chen H., Teramura Y., Iwata H. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid. J Control Release 2011, 150:229-234.
16. Okamoto S., Hijikata A., Kikumoto R., Tonomura S., Hara H., Ninomiya K., et al. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion. Biochem Biophys Res Commun 1981, 101:440-446.
17. Pinkse G.G., Bouwman W.P., Jiawan-Lalai R., Terpstra O.T., Bruijn J.A., de Heer E. Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to apoptosis in islets of Langerhans. Diabetes 2006, 55:312-317.
18. Rosenberg L., Wang R., Paraskevas S., Maysinger D. Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 1999, 126:393-398.
19. Howell S.L., Taylor K.W. Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. Biochem J 1968, 108:17-24.
20. Teramura Y., Minh L.N., Kawamoto T., Iwata H. Microencapsulation of islets with living cells using polyDNA-PEG-lipid conjugate. Bioconjug Chem 2010, 21:792-796.
21. Dr. Paul Johnson private communication.